Land: Verenigde Staten
Taal: Engels
Bron: NLM (National Library of Medicine)
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)
Sabel Med LLC
ZINC OXIDE
ZINC OXIDE 0.2 g in 1 g
TOPICAL
OTC DRUG
OTC monograph not final
AFTATE ZINC OXIDE- ZINC OXIDE OINTMENT SABEL MED LLC _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- ZINC OXIDE OINTMENT (1 OZ AND 2 OZ) AFTATE ZINC OXIDE zinc oxide ointment PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:70 356 -326 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH ZINC O XIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 0 .2 g in 1 g INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH PARAFFIN (UNII: I9 O0 E3H2ZE) MINERAL O IL (UNII: T5L8 T28 FGP) CETO STEARYL ALCO HO L (UNII: 2DMT128 M1S) CETETH-2 0 (UNII: I8 35H2IHHX) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:70 356 -326 -0 2 56 g in 1 TUBE; Type 0 : No t a Co mbinatio n Pro duct 0 5/0 1/20 16 2 NDC:70 356 -326 -0 1 28 g in 1 TUBE; Type 0 : No t a Co mbinatio n Pro duct 0 5/0 1/20 16 Sabel Med LLC MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE OTC mo no graph no t final pa rt348 0 5/0 1/20 16 LABELER - Sabel Med LLC (091476000) Revised: 4/2016 Lees het volledige document